Fluvastatin mitigates SARS-CoV-2 infection in human lung cells

Summary: Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat hypercholesterolemia, is associated with a better disease outcome. Whether statins directly affect virus replication or influence the clinical outcome through modulation of immune responses is unk...

Description complète

Détails bibliographiques

Auteurs principaux:	Francisco J. Zapatero-Belinchón, Rebecca Moeller, Lisa Lasswitz, Marco van Ham, Miriam Becker, Graham Brogden, Ebba Rosendal, Wenjie Bi, Belén Carriquí-Madroñal, Koushikul Islam, Annasara Lenman, Antonia P. Gunesch, Jared Kirui, Thomas Pietschmann, Anna K. Överby, Lothar Jänsch, Gisa Gerold
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	Drugs Virology Science Q
Accès en ligne:	https://doaj.org/article/34bc37bb80fe4e8db30733cdbb761e1b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!